Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of Cancer

被引:1
作者
Wagenaar, HC
Trimbos, JBMZ
Teodorovic, I
Therasse, P
机构
[1] Leiden Univ, Med Ctr, Dept Gynaecol, Staff Ctr Gynecol K6, NL-2300 RC Leiden, Netherlands
[2] EORTC Data Ctr, Brussels, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Gynecol Oncol, Leuven, Belgium
关键词
cancer; European Organisation for Research and Treatment of Cancer; fellowship; Gynaecological Cancer Group; multicenter studies;
D O I
10.1159/000075380
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In 1962, the European Organisation for Research and Treatment of Cancer (EORTC) was founded, and in the course of the years it developed into the leading European organisation in cancer research. Currently, the EORTC is organised into (Pre-)Clinical Groups and Task Forces consisting of scientists and/or clinicians. One of these groups with a specific area of interest in cancer research is the Gynaecological Cancer Group (GCG). The EORTC offers fellowship programmes to physicians and scientists from all over the world to create a possibility to be temporarily linked to an EORTC group or a specific research project. Over the past decade, 76 research fellowships have been appointed at the EORTC Data Center. This paper shows an overview of the activities of one EORTC/GCG medical fellow. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 8 条
[1]  
*EORTC, 2000, EORTC INV HDB
[2]  
*EORTC ED TRAIN DI, 1998, CANC CLIN TRIALS MET
[3]  
*FORTC, 2000, ORG ACT CURR RES
[4]   Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC gynaecological cancer cooperative group study [J].
Pecorelli, S ;
Wagenaar, HC ;
Vergote, IB ;
Curran, D ;
Beex, LVA ;
Wiltshaw, E ;
Vermorken, JB .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) :1331-1337
[5]   Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva:: An EORTC Gynaecological Cancer Cooperative Group study [J].
Wagenaar, HC ;
Colombo, N ;
Vergote, I ;
Hoctin-Boes, G ;
Zanetta, G ;
Pecorelli, S ;
Lacave, AJ ;
van Hoesel, Q ;
Cervantes, A ;
Bolis, G ;
Namer, M ;
Lhommé, C ;
Guastalla, JP ;
Nooij, MA ;
Poveda, A ;
di Palumbo, VS ;
Vermorken, JB .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :348-354
[6]  
Wagenaar HC, 2001, EUR J GYNAECOL ONCOL, V22, P187
[7]   Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer [J].
Wagenaar, HC ;
Trimbos, JBMZ ;
Postema, S ;
Anastasopoulou, A ;
van der Geest, RJ ;
Reiber, JHC ;
Kenter, GG ;
Peters, AAW ;
Pattynama, PMT .
GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :474-482
[8]   Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study [J].
Wagenaar, HC ;
Pecorelli, S ;
Mangioni, C ;
van der Burg, MEL ;
Rotmensz, N ;
Anastasopoulou, A ;
Zola, P ;
Veenhof, CHN ;
Lacave, AJ ;
Neijt, JP ;
van Oosterom, AT ;
Einhorn, N ;
Vermorken, JB .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) :1624-1628